BHARAT BIOLOGICAL & IMMUNOLOGICAL CORPORATION As Per Day Chart Analysis ABOVE 46 TARGET 50 Though DII been in selling spree but DII Buying had been highly to be noted DATE FII DII 21.12.2022 1119.11 cr (Net Selling) 1757.37 cr (Net Buying) 22.12.2022 928.63 cr (Net Buying) 2206.59 cr (Net Buying) 23.12.2022 706.84 cr (Net Selling) 3398.98 cr (Net Buying) Happy...
BIBCL is showing channeling. Buy on Rs. 35. Stop loss Rs.34. Target Rs. 107 (203%)
Price moving further up to reach the previous ATH and closed strong and no doubt it will move up considerably . . . I tried to buy this @ 14 -18 rupees and never get a chance, so its only a watch game for me. Anyone holding this from lower levels can leave a message . . .
As these guys are getting there vaccines for this pandemic the stocks moves high on every day and there is no chance for the retail traders to get in to the trade. As you see from the beginning of this stock behavior when these stock reaches 6 levels it bounces back to 50+ levels and then fall back to 6 levels and once again 50+ and these repeats for years. But...
Bharat Biotech are together developing nasal vaccine for corona. Clinical trial stage soon. what is the possible impact on share price? must watch long
Reversal confirmation on D Volume Support Target 29.25 / 49 SL 20.7 Duration: 4 months (estimate)
Bharat Immunologicals & Biologicals Corporation Ltd. Awaited a strength candle with C> 25.25 on D for upside CCI D>100 Target 27 Duration 1-2 weeks after BoxBO
Go long with small SL 25-27 for 55 swing target